Sign in: Staff/Students
Professor Peter Clegg discusses research performance
More than 100 scientists attended the Institute of Ageing and Chronic Disease’s (IACD) Annual Away Day, reflecting an impressive period of growth.
The event, which brought staff and students together from IACD’s three major research groups, came hot on the heels of the announcement of major funding for the UK’s first Centre for Integrated Research into Musculoskeletal Ageing.
Held in the University’s Foresight Centre, the day began with an introduction from IACD Head of Institute, Professor Malcolm Jackson and Institute manager, Tom West, before Dr Eithne Comerford and Sue Jones delivered an insight into current postgraduate programmes.
This was followed by a musculoskeletal research overview from Professor John Innes and rising star, Dr Liz Laird, who talked about her research into age-related fibroses. Professor Simon Harding then delivered an update on developments in Department of Eye and Vision Sciences, introducing Dr Yalin Zheng.
The day included breakout sessions to increase collaboration and develop IACD’s new Annual Review publication, while a talk on research performance from Deputy Director Professor Peter Clegg and Research Coordinator Diane Ashton allowed for discussion, on subjects such as ensuring effective internal peer review and the early identification of large bids.
Professor Anne McArdle spoke of the Institute’s “vast expertise in musculoskeletal biology” and the “wide array of technologies” available, before introducing Giorgios Sakellariou, who was handpicked from the post-doctoral programme to explore his current research into the mechanisms by which ageing leads to weakness in the elderly.
Professor John Wilding spoke of the Department of Obesity and Endocrinology’s increasingly vital role, as the country faces an “obesity epidemic”.
He was joined by colleague Dr Dan Cuthbertson who elaborated on research being carried out into non alcoholic fatty liver disease.
Dr Cuthbertson said: “If you look at weight and BMI, it doesn’t tell the whole story. What we are now beginning to look at is patients with normal weight who have a number of the complications associated with obesity, like hypertension and fatty liver disease, that you wouldn’t predict they would have by their weight. The flip side of this is a significant proportion, around 30%, despite significant obesity have very few of the complications you would expect to see.”
IACD Director, Professor Malcolm Jackson said: “We cover an area in which there is a lot of interest, because of the changing demographics of the population. The number of elderly people is increasing dramatically and a lot of funding is going into understanding the health effects of ageing. Our research is key to that.”
Giorgios Sakellariou explores the mechanisms by which ageing leads to weakness in the elderly
You must be logged in to post a comment.
All recent news
Using Liverpool’s e-scooters safely
Llama antibodies have “significant potential” as potent COVID-19 treatment
COVID-19 hospital mortality rates not reducing in patients with history of cancer, study finds
Follow us on social media
Global coronavirus research and innovation network launched
Researchers from @livuniHLS have contributed to new research showing that llama antibodies have 'significant potential' as a #COVID19 treatment.
Published in @NatureComms today, the study was led by @RosFrankInst.
#LivUniCovid | @molvirol | @LivUni_IVES
'COVID vaccines for under-16s: why competent children in the UK can legally decide for themselves.' Read this new @ConversationUK piece by Prof @helenstalford (@LIVEChildRights), Dr Kerry Barry (@LivUni) and Dr @aoifedalylaw (@LawUCC) #vaccine #consent
In this video Neil Gaiman (@neilhimself), patron of the Science Fiction Foundation, introduces some of the wonders and oddities from our holdings!
Did you know that we hold the largest catalogued collection of science fiction in Europe?🚀